MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Cancer Genomics and Diagnostics
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,811 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,811 works in the cohort · of 4,299,418page 26 of 57

Labels cover 10 of 2,811 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,811 of 2,811 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Circulating tumor DNA (ctDNA) determinants of improved outcomes in patients (pts) with advanced solid tumors receiving the ataxia telangiectasia and Rad3-related inhibitor (ATRi), RP-3500, in the phase 1/2a TRESR trial (NCT04497116).
Ezra Y. Rosen, Ian M. Silverman, Elisa Fontana, Elizabeth Katherine Lee, David R. Spigel, Martin Højgaard +13 more
2022· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
What biomarkers (if any) for precise medicine?
Sabrina Strano, Paola Muti, Giovanni Blandino
2015· editorial· en· Aging· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
The return of Dr Jekyll in cancer metastasis
Liliana Attisano, Jeffrey L. Wrana
2012· article· en· The EMBO Journal· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Genomics in Clinical trials for Breast Cancer
David Enoma
2023· review· en· Briefings in Functional Genomics· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
fundno affunlabeled
NCI workshop on ctDNA in cancer treatment and clinical care
Brian S. Sorg, Jung S. Byun, V. Anne Westbrook, James V. Tricoli, James H. Doroshow, Lyndsay N. Harris
2024· article· en· JNCI Journal of the National Cancer Institute· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): An Alliance-led analysis.
Nathan R. Foster, Lindsay A. Renfro, Steven E. Schild, Mary W. Redman, Xiaofei F. Wang, Suzanne E. Dahlberg +7 more
2013· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · metaresearch+metaepi_broadconsensus · none
4
citations
affunlabeled
Personalized cancer care
Susan Doyle-Lindrud
2022· article· en· Journal of the American Association of Nurse Practitioners· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Age Influences on the Molecular Presentation of Tumours
Constance H. Li, Syed Haider, Paul C. Boutros
2020· preprint· en· bioRxiv (Cold Spring Harbor Laboratory)· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)
Alyssa Acebedo, Philippe L. Bédard, Samantha Brown, Evelina Ceca, Michael V. Fiandalo, Hannah E. Fuchs +28 more
2025· article· en· ESMO Real World Data and Digital Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · open_scienceconsensus · none
4
citations
aboutno affunlabeled
Emerging Multi-Cancer Early Detection Technologies
Sinwan Basharat, Jennifer Horton
2022· article· en· Canadian Journal of Health Technologies· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
afffundunlabeled
Joint genotype inference with germline and somatic mutations
Eric Bareke, Virginie Saillour, Jean-François Spinella, Ramón Vidal, Jasmine Healy, Daniel Sinnett
2013· article· en· BMC Bioinformatics· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations

How this was built: Screen · Findings · About